Literature DB >> 1977889

Uptake of glutamate and cysteine in C-6 glioma cells and in cultured astrocytes.

Y Cho1, S Bannai.   

Abstract

The uptake of glutamate in rat glioma C-6 cells and cultured astrocytes derived from rat cerebral hemispheres was found to be mediated by a Na(+)-dependent and a Na(+)-independent system. The Na(+)-dependent system was inhibited by aspartate and was consistent with the commonly occurring system designated system X-AG. The Na(+)-independent system was inhibited by cystine and was consistent with system x-c described in various types of cells in the periphery. It was also found that quisqualate selectively and competitively interfered with the Na(+)-independent glutamate uptake. In C-6 cells, the glutamate uptake via systems X-AG and x-c accounted for approximately 35% and 55% of the total uptake, respectively, at 0.05 mM glutamate. In cultured astrocytes, the glutamate uptake via system X-AG was very potent, whereas the uptake via system xc- was relatively weak and its contribution to the total uptake of glutamate seemed almost negligible. However, in both C-6 cells and astrocytes, system xc- was necessary for the uptake of cystine, another substrate of system xc-. Cystine in the culture medium was an essential precursor of glutathione, and the inhibition of the cystine uptake by excess glutamate as a competitor led to a severe deficiency in glutathione, followed by cell degeneration.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1977889     DOI: 10.1111/j.1471-4159.1990.tb05800.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  44 in total

1.  Extracellular glutamate and other metabolites in and around RG2 rat glioma: an intracerebral microdialysis study.

Authors:  P F Behrens; H Langemann; R Strohschein; J Draeger; J Hennig
Journal:  J Neurooncol       Date:  2000-03       Impact factor: 4.130

Review 2.  Interrelationship between retinal ischaemic damage and turnover and metabolism of putative amino acid neurotransmitters, glutamate and GABA.

Authors:  L N Robin; M Kalloniatis
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

3.  Regulation of system x(c)(-)activity and expression in astrocytes by interleukin-1β: implications for hypoxic neuronal injury.

Authors:  Nicole A Jackman; Tracy F Uliasz; James A Hewett; Sandra J Hewett
Journal:  Glia       Date:  2010-11-15       Impact factor: 7.452

Review 4.  Glutamate transporters in brain ischemia: to modulate or not?

Authors:  Weronika Krzyżanowska; Bartosz Pomierny; Magłorzata Filip; Joanna Pera
Journal:  Acta Pharmacol Sin       Date:  2014-03-31       Impact factor: 6.150

5.  Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange.

Authors:  Z C Ye; J D Rothstein; H Sontheimer
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

6.  Modulation of [3H]dopamine release by glutathione in mouse striatal slices.

Authors:  Réka Janáky; Róbert Dohovics; Pirjo Saransaari; Simo S Oja
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

7.  Vesicular and non-vesicular glutamate release in the nucleus accumbens in conditions of a forced change of behavioral strategy.

Authors:  N B Saul'skaya; M O Mikhailova
Journal:  Neurosci Behav Physiol       Date:  2005-09

8.  Comparative study of the uptake of L-cysteine and L-cystine in the renal proximal tubule.

Authors:  S Riahi-Esfahani; H Jessen; H Røigaard
Journal:  Amino Acids       Date:  1995-09       Impact factor: 3.520

Review 9.  Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity.

Authors:  Evan Noch; Kamel Khalili
Journal:  Cancer Biol Ther       Date:  2009-10       Impact factor: 4.742

10.  Glucose metabolites, glutamate and glycerol in malignant glioma tumours during radiotherapy.

Authors:  Pedram Tabatabaei; Per Bergström; Roger Henriksson; A Tommy Bergenheim
Journal:  J Neurooncol       Date:  2008-06-19       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.